evernorth glp-1 Cigna's launches Wegovy, Zepbound copayment cap Evernorth reaches deals with Novo

During holiday gatherings, people tend to consume more than their usual meals (and with greater frequency)

A recent analysis calculated an estimated number needed to harm of 1,066 associated with a DPP-4 inhibitor therapy (12, 4749)

Similar content being viewed by others 1 Background, aim, and scope Pharmaceuticals in the aquatic environment became an issue of increasing importance over the last years

Perez-Dominguez F, Carrillo-Beltrn D, Blanco R, Muoz JP, Len-Cruz G, Corvalan AH, et al

This review seeks to provide a comprehensive analysis of these developments in GLP-1 formulation and delivery systems, along with insights into how these modifications enhance the efficacy and utility of GLP-1-based therapies